Subha Mukherjee1, Wilfred A van der Donk. 1. Department of Chemistry and Howard Hughes Medical Institute, University of Illinois at Urbana-Champaign , 600 South Mathews Avenue, Urbana, Illinois 61801, United States.
Abstract
Lanthipeptides are a class of post-translationally modified peptide natural products. They contain lanthionine (Lan) and methyllanthionine (MeLan) residues, which generate cross-links and endow the peptides with various biological activities. The mechanism of a highly substrate-tolerant lanthipeptide synthetase, ProcM, was investigated herein. We report a hybrid ligation strategy to prepare a series of substrate analogues designed to address a number of mechanistic questions regarding catalysis by ProcM. The method utilizes expressed protein ligation to generate a C-terminal thioester of the leader peptide of ProcA, the substrate of ProcM. This thioester was ligated with a cysteine derivative that resulted in an alkyne at the C-terminus of the leader peptide. This alkyne in turn was used to conjugate the leader peptides to a variety of synthetic peptides by copper-catalyzed azide-alkyne cycloaddition. Using deuterium-labeled Ser and Thr in the substrate analogues thus prepared, dehydration by ProcM was established to occur from C-to-N-terminus for two different substrates. Cyclization also occurred with a specific order, which depended on the sequence of the substrate peptides. Furthermore, using orthogonal cysteine side-chain protection in the two semisynthetic peptide substrates, we were able to rule out spontaneous non-enzymatic cyclization events to explain the very high substrate tolerance of ProcM. Finally, the enzyme was capable of exchanging protons at the α-carbon of MeLan, suggesting that ring formation could be reversible. These findings are discussed in the context of the mechanism of the substrate-tolerant ProcM, which may aid future efforts in lanthipeptide engineering.
Lanthipeptides are a class of post-translationally modifiedpeptide natural products. They contain lanthionine (Lan) andmethyllanthionine (MeLan) residues, which generate cross-links and endow the peptides with various biological activities. The mechanism of a highly substrate-tolerant lanthipeptide synthetase, ProcM, was investigated herein. We report a hybrid ligation strategy to prepare a series of substrate analogues designed to address a number of mechanistic questions regarding catalysis by ProcM. The method utilizes expressed protein ligation to generate a C-terminal thioester of the leader peptide of ProcA, the substrate of ProcM. This thioester was ligated with a cysteinederivative that resulted in an alkyne at the C-terminus of the leader peptide. This alkyne in turn was used to conjugate the leader peptides to a variety of syntheticpeptides by copper-catalyzedazide-alkynecycloaddition. Using deuterium-labeledSer andThr in the substrate analogues thus prepared, dehydration by ProcM was established to occur from C-to-N-terminus for two different substrates. Cyclization also occurred with a specific order, which depended on the sequence of the substrate peptides. Furthermore, using orthogonal cysteine side-chain protection in the two semisyntheticpeptide substrates, we were able to rule out spontaneous non-enzymaticcyclization events to explain the very high substrate tolerance of ProcM. Finally, the enzyme was capable of exchanging protons at the α-carbon of MeLan, suggesting that ring formation could be reversible. These findings are discussed in the context of the mechanism of the substrate-tolerant ProcM, which may aid future efforts in lanthipeptide engineering.
Lanthipeptides are
a class of ribosomally synthesized and post-translationally
modifiedpeptides (RiPPs[1]) that contain
the characteristicthioether residues lanthionine (Lan) andmethyllanthionine
(MeLan).[2,3] A subclass of lanthipeptides with
antibacterial activity is known as lantibiotics,[4] which are effective against many Gram-positive bacteria
including some drug-resistant species.[5] For instance, nisin has been used for over 50 years as a preservative
in the food industry to combat food-borne pathogens without significant
bacterial resistance.[6] Lanthipeptides
that do not display antibacterial activity can exert antiviral,[7] antiallodynic,[8] antinociceptive,[9] and morphogenic[10] activities. Cyclicpeptides such as lanthipeptides
are also increasingly recognized as promising compounds for disrupting
protein–protein interactions.[11−16] Investigation of the synthetases that post-translationally generate
lanthipeptides would aid in engineering efforts to produce molecules
with desirable properties.[17−19]During lanthipeptide biosynthesis,
the ribosomal machinery first
synthesizes linear precursor peptidescalledLanAs.[3] The LanA peptidecomprises an N-terminal leader peptide
that is believed to serve several possible roles, including recognition
by the synthetase,[20,21] and a C-terminal core peptide
that is post-translationally modified. Proteolyticcleavage then removes
the leader peptide to produce the final lanthipeptide (Figure 1A).[1] Lan and MeLan formation
involves first the dehydration of Ser andThr residues to generate
dehydroalanine (Dha) anddehydrobutyrine (Dhb), respectively.
The dehydrated residues then undergo Michael-type addition by the
side-chain thiol of cysteines to generate the thioethersLan and MeLan,
respectively (Figure 1B).[22]
Figure 1
(A) Generic scheme for lanthipeptide biosynthesis. (B) Common post-translational
modifications in lanthipeptides.
(A) Generic scheme for lanthipeptide biosynthesis. (B) Common post-translational
modifications in lanthipeptides.Prochlorosins are a large group of lanthipeptides produced
by marine cyanobacteria of the genus Prochlorococcus. In Prochlorococcus MIT9313, a single
enzyme, ProcM, catalyzes the post-translational modification of 29
different substrates (ProcAs), thereby generating many distinct thioether
ring topologies within the 29 prochlorosin products (Pcns; Supporting Information Figure S1).[23] As such, the Pcn biosynthetic system is intriguing
with respect to the details of thioether ring formation that may explain
the remarkable diversity of the products formed by ProcM. A previous
study suggested that the enzyme might generate a subset of the thioether
rings, which would then preorganize the substrate to facilitate non-enzymaticcyclization of the other rings,[23] as illustrated
schematically for a substrate with two thioether rings in Figure S2.
Investigation of the stereochemistry of the thioether rings
in a subset of Pcns showed that they all had the dl stereochemistry
(2S,6R-Lan and 2S,3S,6R-MeLan),[24] identical to what has been observed for the majority of
lanthipeptides analyzed to date.[22] Though this conserved stereochemistry of Michael-type addition
suggested enzymaticcyclization, non-enzymaticcyclization of preorganized
intermediates with high stereoselectivity could not be ruled
out because in previous biomimetic studies of lanthipeptide biosynthesis
non-enzymaticcyclization also took place with high selectivity for
the dl stereoisomers.[25−27] In this study, we experimentally
probed a potential role of non-enzymaticcyclization in prochlorosin
maturation.The substrate-tolerant synthetase ProcM dehydrates
core peptidescontaining a variety of sequences with different residues flanking
Ser andThr and also with different numbers of intervening residues
(Figure S1). Currently, it is not known whether ProcM dehydrates its
substrates in a directional fashion and whether any observeddirectionality
is general for different substrates. In this study, we expanded upon
a previously reported strategy[28] to assign
the directionality of dehydration of substrates by ProcM. Additional
experiments also revealed the order of ProcM-catalyzedcyclization
of these substrates.In the 29 prochlorosins with diverse
ring topologies produced
by ProcM, often a single ring structure out of several possible topologies
is observed (Figure S1B).[23,24] The observed high site
selectivity in prochlorosincyclization could be the result
of either thermodynamic or kineticcontrol. Thermodynamiccontrol would require the reversible installation of thioether rings,
which ultimately results in the ring topology with the lowest free
energy. On the other hand, kineticcontrol would lead to thioether
ring formation involving the lowest activation energy barrier. A previous
study on the biomimeticcyclization of nisin’s B-ring
suggested that non-enzymaticthioether ring formation is governed
by kineticcontrol and that the Michael-type addition is irreversible.[29] In the current study, the reversibility of cyclization
in the presence of ProcM was investigated.
Results
Choice of Substrates
Two core peptides were chosen
for investigation out of the repertoire of 29 possible substrates.
The first choice was ProcA2.8, which is transformed into prochlorosin
(Pcn) 2.8, a product with two non-overlapping lanthionine rings (Figure 2A). In the majority of the lanthipeptidesdiscovered to date, the thioether rings are installed by nucleophilic
attack of cysteines onto dehydrated residues that are located toward
the N-terminus. However, in prochlorosins, the thioether rings
are formed by Cys residues located on either side of the dehydrated
residues, as illustrated for Pcn2.8 generated from ProcA2.8 (Figure 2; see also Figure S1). Thus, studies with Pcn2.8
could reveal whether perhaps enzymaticcyclization forms rings in
one direction and non-enzymaticcyclization forms thioether rings
in the opposite direction. In addition, we selectedPcn3.3, a compoundcontaining overlapping thioether rings, to probe the effect of substrate
preorganization on non-enzymatic ring formation (Figure 2B). As described below, for both substrates, we determined
the order of dehydration andcyclization and investigated the possibility
of non-enzymaticcyclization and reversibility as determinants of
the ring topology.
Figure 2
Structures of prochlorosins 2.8 and 3.3. The fragments
of the Lan/MeLan
residues originating from Cys are in red, and those originating from
Ser/Thr residues are in blue.
Structures of prochlorosins 2.8 and 3.3. The fragments
of the Lan/MeLan
residues originating from Cys are in red, and those originating from
Ser/Thr residues are in blue.
ProcM Dehydrates ProcA2.8 Precursor Peptide in C-to-N-Terminal
Fashion
Previous studies on LanM lanthipeptide synthetases
showed that dehydration is directional, moving from the N-terminus
to the C-terminus of the substrate.[30] To
investigate whether this would also be the case for the substrate-tolerant
ProcM, we used the methoddeveloped by Süssmuth andco-workers,[28] in which specificSer residues are replaced
by 2,3,3-deuterium-labeledserine. In such substrates, dehydration
of unlabeledSer involves loss of 18 Da (−H2O) while
dehydration of the labeledserine results in loss of 19 Da (−HDO;
Figure 3A,B). The lanthipeptide synthetase
ProcM requires an N-terminal leader peptide for maturation of the
precursor peptide.[23] The highly conserved
leader peptide is ca. 65 amino acid residues long, and the highly
variable core peptidescomprise between 13 and 32 amino acid residues
(Figure S1), resulting in a precursor peptide that is too long to
prepare conveniently by linear solid phase peptide synthesis (SPPS).
Instead, we used expressed protein ligation (EPL)[31] to generate full-length precursor peptidescontaining deuterium-labeledserine. The ProcA2.8 core peptide has a cysteine at position 3 that
can be used for EPL. Peptide 1 corresponding to the ProcA2.8
leader peptide with two additional Ala residues from the N-terminus
of the ProcA2.8 core peptide was generated with a peptide thioester
at the C-terminus using intein chemistry (Figure 4). Two ProcA2.8 core peptides 2 and 3 spanning residues 3–19 were synthesized by SPPS with Ser13
or Ser9 replaced with 2,3,3-deuterium-labeledSer (Figure 4). Native chemical ligation of 2 and 3 with ProcA2.8 leader-AA-thioester 1 afforded
the substrates 4 and 5 (Figure 5A,C). These substrates were treated with ProcM,
and after various time points, ProcM was removed from a portion of
the assay by ultrafiltration. The filtrate was incubated with
endoproteinase GluC to remove most of the leader peptide, and
the digest was analyzed by matrix-assisted laserdesorption/ionization
time-of-flight (MALDI-TOF) and electrospray ionization (ESI) mass
spectrometry. With both substrates, the ESI and MALDI-TOF mass spectrometric
analyses showed that Ser13 was dehydrated prior to Ser9 (Figure 5B,D and Figures S3 and S4).
Figure 3
Strategy for determination
of directionality of dehydration using
[2,3,3-2H]-Ser or [2,3-2H]-Thr residues. (A)
Dehydration of Ser incurs a loss of 18 Da. (B) Dehydration of labeled
Ser results in a loss of 19 Da. (C) Dehydration of Thr incurs a loss
of 18 Da. (D) Dehydration of labeled Thr results in a loss of 19 Da.
By tracking which dehydration involves a loss of 19 Da, directionality
of dehydration can be established.[28]
Figure 4
Schematic representation of ProcA2.8 leader-AA-MESNa
thioester
(1), ProcA2.8 core peptide Δ1–2 with Ser13
replaced with [2,3,3-2H]-Ser (2), and ProcA2.8
core peptide Δ1–2 with Ser9 replaced with [2,3,3-2H]-Ser (3).
Figure 5
Directionality of dehydration of wt ProcA2.8. (A) Structure of
ProcA2.8 precursor peptide 4 assembled using EPL with
Ser13 replaced with [2,3,3-2H]-Ser. (B) MALDI-TOF MS of 4 partially dehydrated by ProcM and digested by GluC. (C)
Structure of ProcA2.8 precursor peptide 5 assembled using
EPL with Ser9 replaced with [2,3,3-2H]-Ser. (D) MALDI-TOF
MS of 5 partially dehydrated by ProcM and digested by
GluC.
Strategy for determination
of directionality of dehydration using
[2,3,3-2H]-Ser or [2,3-2H]-Thr residues. (A)
Dehydration of Ser incurs a loss of 18 Da. (B) Dehydration of labeledSer results in a loss of 19 Da. (C) Dehydration of Thr incurs a loss
of 18 Da. (D) Dehydration of labeledThr results in a loss of 19 Da.
By tracking which dehydration involves a loss of 19 Da, directionality
of dehydrationcan be established.[28]Schematic representation of ProcA2.8 leader-AA-MESNa
thioester
(1), ProcA2.8 core peptide Δ1–2 with Ser13
replaced with [2,3,3-2H]-Ser (2), and ProcA2.8
core peptide Δ1–2 with Ser9 replaced with [2,3,3-2H]-Ser (3).Directionality of dehydration of wt ProcA2.8. (A) Structure of
ProcA2.8 precursor peptide 4 assembled using EPL with
Ser13 replaced with [2,3,3-2H]-Ser. (B) MALDI-TOF MS of 4 partially dehydrated by ProcM anddigested by GluC. (C)
Structure of ProcA2.8 precursor peptide 5 assembled using
EPL with Ser9 replaced with [2,3,3-2H]-Ser. (D) MALDI-TOF
MS of 5 partially dehydrated by ProcM anddigested by
GluC.Although EPL worked well to determine
the directionality of dehydration
of ProcA2.8, other substrates do not always have a conveniently locatedCys. Hence, we evaluated another hybrid ligation strategy based on
both EPL andcopper-catalyzedalkyne–azidecycloaddition
(CuAAC).[32,33] In previous studies on lacticin 481 synthetase,
an alkyne-containing leader peptide was generated by chemical synthesis,[34,35] but in this work, we elected to generate the much longer ProcA leader
peptide by heterologous expression in Escherichia coli as a fusion protein to an intein andchitin-binding domain.[36] Given the high-sequence similarity of the leader
peptides of prochlorosin precursors (Figure S1), the ProcA3.2
leader peptide was arbitrarily chosen for the designed precursor peptides.
The C-terminal Gly of the ProcA3.2 leader peptide was mutated to Lys
to allow efficient cleavage of the peptide thioester linkage to the
chitin resin by 2-mercaptoethanesulfonate sodium salt
(MESNa),[37] and to introduce a LysC endoproteinase
cleavage site C-terminal to the leader peptide. EPL of the MES-thioester
with (R)2-amino-N-(but-3-yn-1-yl)-3-mercaptopropionamide
(6, Figure 6) generated the leader
peptide with a C-terminal alkyne modification (Figure S5). The cysteine
residue incorporatedduring EPL was protected with iodoacetamide
to prevent any potential interference in the enzymaticcyclization
reaction (Figure S5).
Figure 6
Structure of building block 6 used to attach
an alkyne
at the C-terminus of the leader peptide by EPL. Building block 7 was used for installation of a photocleavable triazole
linker between the leader and the core peptides. The building block 8 was used to facilitate the click reaction via a copper-chelating
group.
Structure of building block 6 used to attach
an alkyne
at the C-terminus of the leader peptide by EPL. Building block 7 was used for installation of a photocleavable triazole
linker between the leader and the core peptides. The building block 8 was used to facilitate the click reaction via a copper-chelating
group.The core peptides of ProcA2.8
were then synthesized by SPPS, again
incorporating deuterium-labeledSer at positions 9 and 13. In the
last step prior to cleaving the peptides from the resin, the CuAAC
ligation handles 7 or 8 (Figure 6) were coupled to their N-termini. The building
block 7 would enable convenient removal of the leader
peptide by photolysis,[38] whereas building
block 8 was expected to improve the efficiency of the
ligation owing to the copper ligating ability of the pyridine ligand.[39] Two ProcA2.8 precursor peptides 9 and 10 were thus synthesized by CuAAC to probe directionality
of dehydration (Figure 7A,C). The substrates
were treated with ProcM, and at several time points, ProcM was removed
from a portion of the assay by ultrafiltration; the filtrate
was incubated with protease LysC and the digest analyzed by MALDI-TOF
MS (Figures S6 and S7). With both substrates 9 and 10, the analysis showed that Ser13 was dehydrated prior to
Ser9, indicating C-to-N-terminal dehydration (Figures 7B,D). This observation demonstrated that the presence of a
triazole linker in the designed substrate did not affect the directionality
of dehydration. Furthermore, GC–MS analysis of the product
revealed the presence of Lan rings of the same dl stereochemistry
as in the wild-type (wt) product (Figure S8), thus suggesting that
ProcM correctly recognizes the substrate with a triazole linker between
leader andcore peptides. The observation that the substrate analogue
generated by CuAAC furnished the same product and with the same directionality
as with native substrate enabled us to extend our investigation of
directionality of dehydration to other substrates where the sequence
of the core peptidedoes not allow EPL to assemble the native precursor
peptide.
Figure 7
Directionality of dehydration in ProcA2.8 analogues. (A) Structure
of ProcA2.8 precursor peptide 9 with Ser13 replaced with
[2,3,3-2H]-Ser. (B) MALDI-TOF MS of 9 partially
dehydrated by ProcM and after LysC cleavage. (C) Structure of ProcA2.8
precursor peptide 10 with Ser9 replaced with [2,3,3-2H]-Ser. (D) MALDI-TOF MS of 10 partially dehydrated
by ProcM and after LysC cleavage.
Directionality of dehydration in ProcA2.8 analogues. (A) Structure
of ProcA2.8 precursor peptide 9 with Ser13 replaced with
[2,3,3-2H]-Ser. (B) MALDI-TOF MS of 9 partially
dehydrated by ProcM and after LysCcleavage. (C) Structure of ProcA2.8
precursor peptide 10 with Ser9 replaced with [2,3,3-2H]-Ser. (D) MALDI-TOF MS of 10 partially dehydrated
by ProcM and after LysCcleavage.
Directionality of Dehydration of ProcA3.3 by ProcM
To probe
directionality of dehydration in prochlorosinscontaining
threonine residues and overlapping rings, we prepared the ProcA3.3
derivatives 12 and 13 with either Thr18
or Thr11 replaced with [2,3-2H]-Thr, respectively (Figure 8A,C). The peptides were treated with ProcM and after
various time points, the enzyme was removed by ultrafiltration. The
filtrate was incubated with endoproteinase GluC to remove most
of the leader peptide, and the digest was analyzed by MALDI-TOF MS.
The data demonstrated that Thr18 was dehydrated first followed by
Thr11 andThr3 (Figure 8B,D and Figures S9
and S10), in agreement with the overall C-to-N-terminal dehydration
observed with ProcA2.8.
Figure 8
Directionality of dehydration of ProcA3.3 analogues
containing
a triazole linker. (A) Structure of ProcA3.3 analogue 12 with Thr18 replaced with [2,3-2H]-Thr. (B) MALDI-TOF
MS of 12 partially dehydrated by ProcM and digested by
GluC. (C) Structure of ProcA3.3 analogue 13 with Thr11
replaced with [2,3-2H]-Thr. (D) MALDI-TOF MS of 13 partially dehydrated by ProcM and digested by GluC.
Directionality of dehydration of ProcA3.3 analogues
containing
a triazole linker. (A) Structure of ProcA3.3 analogue 12 with Thr18 replaced with [2,3-2H]-Thr. (B) MALDI-TOF
MS of 12 partially dehydrated by ProcM anddigested by
GluC. (C) Structure of ProcA3.3 analogue 13 with Thr11
replaced with [2,3-2H]-Thr. (D) MALDI-TOF MS of 13 partially dehydrated by ProcM anddigested by GluC.To confirm that the observeddirectionality of
dehydration of wt
ProcA3.3 was the same as that of the analogues 12 and 13, tandem MS was used to analyze partially dehydrated wild-type
ProcA3.3. The order of dehydration of Thr11 andThr18cannot be distinguished
by this method because of the overlapping rings of prochlorosin 3.3,
but the timing of dehydration of Thr3can be determined. Using ultraperformance
liquidchromatography (UPLC) coupled with ESI-MS, peptide ions with
predominantly two-folddehydration were analyzed (Figure S11A). The
ion was fragmented, and the observed fragment ions demonstrated that
Thr3 escapeddehydration in the two-folddehydrated ProcA3.3 (Figure
S11B), in agreement with the conclusion that we reached from studies
on the triazole-containing ProcA3.3 precursor peptide (i.e., Thr3
is dehydrated last).
Directionality of Cyclization by ProcM
ProcM was incubated
with expressed and purified His6-ProcA2.8 obtained as reported
previously,[23] and the assay was quenched
by removing ProcM at various time points. After incubation with endoproteinase
LysC to remove most of the leader peptide, the digest was treated
with iodoacetamide (IAA). Any noncyclizedthiol would react
with IAA, and the enzymatic assay conditions were optimized to allow
buildup of an incompletely cyclized intermediate that resulted in
one IAA adduct (Figure S12A). ESI-MS/MS was performed on this peptide,
andCys3 was found to be alkylated (Figure S12B). The fragmentation
pattern suggested that the B-ring had formed in this intermediate.
Hence, cyclization of Cys19 occurred prior to Cys3, suggesting C-to-N-terminal
directionality of cyclization.ProcM was also incubated with
His6-ProcA3.3, and the assay was quenched by removing ProcM
at various time points. After endoproteinase LysCdigestion,
the peptides were treated with IAA. The ProcM assay conditions were
again optimized to trap an intermediate that resulted in one IAA adduct
(Figure S13A). The observed fragmentation pattern of this peptide
by ESI-MS/MS showed that Cys21 was alkylated, suggesting that Cys14
had formed a thioether ring with Dhb18 (Figure S13B). The data suggest
that cyclization of ProcA3.3 may not take place with C-to-N-terminal
directionality, but that instead the MeLan ring between Cys14 andDhb18 is formed in the monocyclic intermediate (see Figure 2 for the Pcn3.3 ring topology).
Substrate Design
To Probe Non-enzymatic Cyclization in Prochlorosin
Maturation
To address whether non-enzymaticcyclization assists
ProcM in the maturation of substrates with variable ring topologies,
substrates were designed that restrict ProcM installation to selectedthioether rings by orthogonal protection of a subset of cysteine thiols
in the core peptide. Release of the protecting group would generate
an intermediate that would allow investigation of non-enzymaticcyclization
in the presence of other preinstalledthioether rings.A variety
of orthogonal protecting groups for the cysteine thiols were tested. tert-Butyl disulfide protection proved not suitable because
removal by reducing agents like tris(2-carboxyethyl)phosphine
(TCEP) andtributylphosphine formed adducts with dehydrated
residues. Conversely, acetamidomethyl protection was unsuccessful
because its removal required oxidizing agents like iodine, which partially
oxidized the thioether rings. However, the o-nitrobenzyl
and4,5-dimethoxy-o-nitrobenzyl groups were
readily introduced into the peptideduring SPPS[40] and were cleanly released by UV irradiation (365 nm).Hence, four precursor peptides were prepared using the previously
described hybrid EPL/CuAAC ligation strategy (14 and 15 in Figure 9 and 16 and 17 in Figure 10), which were treated
with ProcM to produce the intermediates 18–21 and 25. Photorelease of ortho-nitrobenzyl protecting groups then generated substrates to
probe non-enzymaticcyclizations of each of the rings in ProcA2.8
and ProcA3.3 in the presence of other enzymatically installed rings.
Figure 9
Probing
non-enzymatic cyclization in ProcA2.8. (A) Non-enzymatic
cyclization of the A-ring in the presence of the enzymatically preinstalled
B-ring. Reagents and conditions: (i) HEPES, ATP, TCEP, MgCl2, substrate 14 (50 μM), ProcM (30 μM); (ii)
ProcM was removed, the intermediate 18 was desalted and
lyophilized, dissolved in 0.1% TFA, and irradiated; (iii) the peptide
was dissolved in HEPES buffer (pH 8.0) to allow non-enzymatic cyclization
followed by treatment with iodoacetamide. (B) MALDI-TOF MS analysis
showed that non-enzymatic cyclization was slow and incomplete, as
indicated by the presence of IAA adduct 22. (C) Non-enzymatic
cyclization of the B-ring in ProcA2.8 in the presence of enzymatically
preinstalled A-ring. Reagents and conditions: (i) HEPES, ATP, TCEP,
MgCl2, ProcM (30 μM), substrate 15 (50
μM); (ii) ProcM was removed, intermediate 19 was
irradiated with UV light and lyophilized; (iii) the lyophilized peptide
was dissolved in solution containing all components in (i) except
ProcM, digested with LysC and treated with excess iodoacetamide. (D)
MALDI-TOF MS analysis showed that non-enzymatic cyclization was incomplete,
as indicated by the presence of IAA adduct 23.
Figure 10
Probing non-enzymatic cyclization in
ProcA3.3. (A) Non-enzymatic
cyclization of the A-ring in the presence of enzymatically preinstalled
B-ring. Reagents and conditions: (i) HEPES, ATP, TCEP, MgCl2, substrate 16 (50 μM), ProcM (20 μM); (ii)
ProcM was removed and the intermediate 20 was irradiated
with UV light and lyophilized; (iii) the lyophilized peptide was dissolved
in assay solution containing all components in (i) with or without
ProcM, digested by LysC, and treated with iodoacetamide. (B)
MALDI-TOF MS of solution obtained after treatment in (iii). (C) ProcM
assay of substrate 17 generated a mixture of intermediates 21 and 25. (D) ProcM was removed from the mixture
of 21 and 25, and the product mixture was
irradiated with UV light and lyophilized. The peptide mixture was
dissolved in solution containing all ProcM assay components with or
without ProcM. The products were then treated with LysC and IAA. The
MALDI-TOF MS spectra of the two assays are presented.
Probing
non-enzymaticcyclization in ProcA2.8. (A) Non-enzymaticcyclization of the A-ring in the presence of the enzymatically preinstalled
B-ring. Reagents andconditions: (i) HEPES, ATP, TCEP, MgCl2, substrate 14 (50 μM), ProcM (30 μM); (ii)
ProcM was removed, the intermediate 18 was desalted and
lyophilized, dissolved in 0.1% TFA, and irradiated; (iii) the peptide
was dissolved in HEPES buffer (pH 8.0) to allow non-enzymaticcyclization
followed by treatment with iodoacetamide. (B) MALDI-TOF MS analysis
showed that non-enzymaticcyclization was slow and incomplete, as
indicated by the presence of IAA adduct 22. (C) Non-enzymaticcyclization of the B-ring in ProcA2.8 in the presence of enzymatically
preinstalled A-ring. Reagents andconditions: (i) HEPES, ATP, TCEP,
MgCl2, ProcM (30 μM), substrate 15 (50
μM); (ii) ProcM was removed, intermediate 19 was
irradiated with UV light and lyophilized; (iii) the lyophilizedpeptide
was dissolved in solution containing all components in (i) except
ProcM, digested with LysC and treated with excess iodoacetamide. (D)
MALDI-TOF MS analysis showed that non-enzymaticcyclization was incomplete,
as indicated by the presence of IAA adduct 23.Probing non-enzymaticcyclization in
ProcA3.3. (A) Non-enzymaticcyclization of the A-ring in the presence of enzymatically preinstalled
B-ring. Reagents andconditions: (i) HEPES, ATP, TCEP, MgCl2, substrate 16 (50 μM), ProcM (20 μM); (ii)
ProcM was removed and the intermediate 20 was irradiated
with UV light and lyophilized; (iii) the lyophilizedpeptide was dissolved
in assay solution containing all components in (i) with or without
ProcM, digested by LysC, and treated with iodoacetamide. (B)
MALDI-TOF MS of solution obtained after treatment in (iii). (C) ProcM
assay of substrate 17 generated a mixture of intermediates 21 and 25. (D) ProcM was removed from the mixture
of 21 and 25, and the product mixture was
irradiated with UV light and lyophilized. The peptide mixture was
dissolved in solution containing all ProcM assay components with or
without ProcM. The products were then treated with LysC andIAA. The
MALDI-TOF MS spectra of the two assays are presented.
Efficient Cyclization of ProcA2.8 Requires
ProcM
ProcM
correctly processed the ProcA2.8 precursor peptide analogue 14 to generate the B-ring and a dehydroalanine at the
ninth position of the core peptide (intermediate 18)
(Figure 9A) as demonstrated by tandem MS (Figure
S14). The peptide 18 was irradiated at 365 nm to release
the o-nitrobenzyl group on Cys3 along with
the leader peptide that was attached via linker 7. The
resulting peptide was incubated in buffered solution at pH 8.0 to
probe non-enzymaticcyclization under conditions where enzymaticcyclization
is complete. The peptide was then treated with IAA to report on noncyclizedCys residues. MALDI-TOF MS analysis revealed the predominant presence
of IAA adduct 22, which indicated incomplete non-enzymaticcyclization of the A-ring of prochlorosin 2.8 (Figure 9B). Thus, non-enzymaticcyclization of the A-ring
in the presence of the B-ring is much slower than enzymaticcyclization.
Non-enzymaticcyclization was also conducted at higher pH (pH 8.5)
and for a longer time period (12 h), but non-enzymaticcyclization
of the A-ring still did not proceed to completion.ProcM converted
the ProcA2.8 analogue 15 (Figure 9C) to an intermediate 19 that contained the A-ring of
prochlorosin 2.8 and a dehydroalanine at the 13th position
as evidenced by tandem MS (Figure S15). The peptide 19 was irradiated to remove the o-nitrobenzyl
group from Cys19 and was incubated with ProcM. The peptide was then
treated with LysC to remove the leader peptide and with IAA to probe
cyclization. Analysis by MALDI-TOF MS showed that, whereas the enzymaticcyclization under these conditions is complete in 1 h, the non-enzymaticcyclization still resulted in a mixture of cyclized product andIAA
adduct 23 after 16 h (Figure 9D). Because the observed non-enzymaticcyclization of the B-ring
was very slow compared to enzymaticcyclization, these experiments
do not provide support for efficient non-enzymatic ring formation
facilitated by preorganization upon formation of one of the rings.
Ring Formation in ProcA3.3 Requires ProcM
Treatment
of the ProcA3.3 precursor analogue 16 with ProcM resulted
in the formation of a product containing a dehydrobutyrine (Dhb)
at positions 3 and 11 and a MeLan formed between Cys14 andDhb18 (Figure 10A), as confirmed by tandem MS after LysCcleavage
of 20 (Figure S16). The o-nitrobenzyl
group was removed from Cys21 by UV irradiation, and the peptide was
subjected to both enzymatic and non-enzymatic assay conditions. Following
the cyclization assays, the peptides were digested with endoproteinase
LysC and treated with IAA. The enzymatic assay did not show IAA adduct
formation, whereas the non-enzymatic assay showed predominant formation
of the IAA adduct 24 (Figure 10A) as demonstrated by MALDI-TOF MS (Figure 10B). Hence, non-enzymaticcyclization of the A-ring of Pcn3.3 in a
peptide that already contained the B-ring is much slower than when
this process is catalyzed by ProcM. Thus, the experiments with peptides 18–20 show that non-enzymaticcyclization
is too slow to be kinetically competent to be a part of the overall
process.The product obtained after ProcM treatment of the ProcA3.3
precursor analogue 17 was not a single peptide but a
mixture of peptides 21 and 25 with two different
ring topologies (Figure 10C). The major product 21 had a MeLan formed between Cys21 andDhb18 and the minor
product 25 contained a MeLan formed between Cys21 andDhb11 (as seen in native modified ProcA3.3, Figure 2), as evidenced by tandem ESI-MS on the individual products
that were separated on analytical scale by UPLC (Figure S17A,B). These
findings can be explained on the basis of the order of cyclization
of ProcA3.3 discussed above. In wt ProcA3.3, Cys14 forms a ring with
Dhb18 in the observed monocyclic intermediate, and hence only Dhb11
is available to Cys21 for cyclization. However, in peptide 17, Cys14 is protected, and therefore, both Dhb11 andDhb18 are available
for reaction with Cys21; apparently the enzyme then prefers formation
of the smaller ring between Cys21 andDhb18. Compounds 21 and 25 could not be separated on preparative scale,
and therefore, the mixture was subjected to UV irradiation to release
the o-nitrobenzyl group from Cys14. The mixture
of deprotectedpeptides was subsequently subjected to both enzymatic
and non-enzymaticcyclization assay conditions. The peptides were
then digested with endoproteinase LysC followed by treatment
with IAA. The non-enzymatic assay resulted in the formation of IAA
adduct, thus indicating the absence of significant spontaneous non-enzymaticcyclization in the mixture of two peptides, whereas the enzymatic
assay resulted in complete cyclization as evidenced by the lack of
IAA adduct (Figure 10D). The cyclized product
mixture was separated on analytical scale by UPLC and tandem MS analysis
revealed the identity of the two products obtained from 21 and 25. In addition to the overlapping ring topology
as observed in Pcn3.3 (Figure S18A), an alternate non-overlapping
ring topology was formed (Figure S18B). Hence, manipulation of the
order of cyclization by using Cys protecting groups allows access
to a ring topology not seen with the native substrate.
Reversibility
of Thioether Ring Formation
To test whether
thioether ring installation in prochlorosins is reversible,
ProcA substrates were modified by ProcM in D2O, resulting
in incorporation of one deuterium at each newly formed α-stereocenter
of Lan/MeLan. The modified precursor peptides were then purified and
subjected to standard ProcM assay conditions in unlabeled aqueous
buffer. If the Michael-type addition is reversible, then the incorporateddeuterium would be expected to exchange with a protium in the assay
in unlabeled buffer (Figure 11).
Figure 11
Scheme for
the exchange assay. Substrate is modified by ProcM in
deuterium-labeled buffer to generate product with one deuterium per
Lan/MeLan. Exchange of the installed deuterium was then investigated
by treating the modified precursor peptide with ProcM in unlabeled
buffer. Exchange can occur by abstraction of deuterium followed by
protonation (solid blue arrows) or by retro-Michael-type addition
(dashed blue arrow) and recyclization.
Scheme for
the exchange assay. Substrate is modified by ProcM in
deuterium-labeled buffer to generate product with one deuterium per
Lan/MeLan. Exchange of the installeddeuterium was then investigated
by treating the modified precursor peptide with ProcM in unlabeled
buffer. Exchange can occur by abstraction of deuterium followed by
protonation (solid blue arrows) or by retro-Michael-type addition
(dashed blue arrow) and recyclization.His-tagged ProcA2.8 was heterologously expressed in E. coli and purified and subjected to ProcM with
all assay components dissolved in D2O. ProcM was removed
by ultrafiltration, and the peptide was desalted and lyophilized.
A portion of the lyophilizedpeptide was digested with endoproteinase
GluC to generate the modifiedcore peptide with a five amino acid
overhang at its N-terminus originating from the leader peptide (Figure 12A). As anticipated, both ESI and MALDI-TOF MS analysis
demonstrated the incorporation of two deuterium atoms. The full-length
peptide was then incubated in unlabeled buffer in the presence or
absence of ProcM for 17 h. Exchange of deuterium with protium was
not observed (Figure 12B, red). Hence D–H
exchange did not occur in ProcA2.8 containing two non-overlapping
lanthionine rings, suggesting that such rings are not installed reversibly
for this peptide.
Figure 12
Deuterium incorporation and exchange in ProcA2.8 and ProcA3.3.
(A) Structure of GluC cleaved ProcA2.8 core peptide fragment incorporating
two deuteriums. Residues in purple originate from the leader peptide.
(B) MALDI-TOF MS of GluC cleaved fragment of deuterium-labeled ProcA2.8
(50 μM) after assay without (blue trace) and with ProcM (20
μM) treatment in aqueous buffer (red trace). (C) GluC digested
ProcA3.3 core peptide incorporating two deuteriums. Residues in purple
originate from the leader peptide. (D) MALDI-TOF MS of GluC digested
fragment of modified deuterium-labeled ProcA3.3 (100 μM) without
aqueous ProcM treatment (blue trace) and with aqueous ProcM (40 μM)
treatment (red trace).
Deuterium incorporation and exchange in ProcA2.8 and ProcA3.3.
(A) Structure of GluCcleaved ProcA2.8 core peptide fragment incorporating
two deuteriums. Residues in purple originate from the leader peptide.
(B) MALDI-TOF MS of GluCcleaved fragment of deuterium-labeled ProcA2.8
(50 μM) after assay without (blue trace) and with ProcM (20
μM) treatment in aqueous buffer (red trace). (C) GluCdigested
ProcA3.3 core peptide incorporating two deuteriums. Residues in purple
originate from the leader peptide. (D) MALDI-TOF MS of GluCdigested
fragment of modifieddeuterium-labeled ProcA3.3 (100 μM) without
aqueous ProcM treatment (blue trace) and with aqueous ProcM (40 μM)
treatment (red trace).
To also explore a substrate containing overlapping rings, ProcA3.3
was heterologously expressed and purified. The peptide was modified
by ProcM in D2O, the enzyme was removed from the modifiedpeptide by ultrafiltration, and the product peptide was desalted and
lyophilized. Analysis by MALDI-TOF MS after endoproteinase GluCdigestion demonstrated incorporation of two deuterium atoms as expected
(Figure 12C). The full-length peptide was then
incubated in unlabeled buffer with or without ProcM anddigested with
GluC before mass spectrometric analysis. The modified ProcA3.3 treated
in aqueous buffer without ProcM did not result in any exchange (Figure 12D, blue), but the modified substrate treated in
aqueous buffer with ProcM showed exchange of both deuterium atoms
with protium (Figure 12D, red). Analysis of
the exchange over time at two different concentrations of ProcM revealed
that the exchange was time-dependent anddependent on the concentration
of ProcM (Figure S19). Also, exchange of one deuterium was significantly
faster, with the seconddeuterium exchange requiring higher enzyme
concentration and longer incubation time. Under the conditions of
the assay (100 μM modified ProcA3.3 and 5 μM ProcM), the
exchange of the first deuterium was already detected after short incubation
times (15 min; Figure S19). The dehydration of ProcA3.3 catalyzed
by ProcM under the same conditions is complete at this time point,
but cyclization is still incomplete. Hence, the observeddeuterium
exchange appears kinetically competent with the cyclization process.
D–H Exchange Is Not Observed in ProcA2.8 Substrates with
Ser Mutated to Thr
Given the observation of D–H exchange
in modified ProcA3.3 but not ProcA2.8, it is interesting to note the
differences between the two substrates. Pcn3.3 contains overlapping
rings whereas Pcn2.8 does not, and the rings in Pcn3.3 are formed
by MeLan residues whereas both rings in Pcn2.8 are formed by Lan residues.
To investigate if the lack of exchange in cyclized ProcA2.8 was because
it contains Lan and not MeLan, two mutants of ProcA2.8 were generated
by site-directed mutagenesis—one with Ser9 replaced with Thr
(ProcA2.8-S9T) and another with Ser13 replaced with Thr (ProcA2.8-S13T).
Both substrates were modified by ProcM in D2O, incorporating
two deuterium atoms in the process. The purified products were subjected
to the D–H exchange assay conditions and were digested with
GluC. Subsequent analysis by MALDI-TOF MS revealed that D–H
exchange had not occurred (Figure S20A–D). Hence, in ProcA2.8
with two non-overlapping rings, even changing a Lan to a MeLandoes
not lead to D–H exchange, suggesting that ring topology may
insteaddictate whether ProcM can exchange the α-proton of the
cross-linked amino acids.
Exchange in ProcA3.3 Involves the B-Ring
As noted above,
the exchange process for cyclized ProcA3.3 involves one deuterium
that was exchanged relatively rapidly with a proton from solvent,
whereas the seconddeuterium exchange was much slower. Because cyclization
of ProcA3.3 results in a ring within a ring, tandem MS could not be
used to determine which of the two MeLan residues is associated with
the faster exchange. We therefore mutatedThr11 to Ser such that cyclization
would result in one Lan and one MeLan, which in principle can be distinguished
by GC–MS after acidic hydrolysis of the product. Thus, ProcA3.3-T11S
was first incubated with ProcM under the standardconditions in D2O. The resulting product was purified and shown to contain
two deuterium atoms by mass spectrometry (Figure S21B). The labeledpeptide was then treated with ProcM in unlabeled buffer, resulting
in relatively rapid exchange of one deuterium (Figure S21C), similar
to the observations with wild-type ProcA3.3. The resulting peptidecontaining one deuterium was then hydrolyzed, and the Lan and MeLan
residues were derivatized as previously described.[41,42] Analysis by GC–MS resulted in detection of unlabeledderivatized
MeLan anddeuterium-labeledderivatizedLan (Figure S22). Hence, the
relatively fast exchange occurs in the MeLan in ring B. Both Lan and
MeLan residues had the correct dl stereochemistry as
confirmed by co-injection with synthetic standards (Figure S23).
Discussion
In an effort to understand the remarkable substrate
tolerance of
ProcM, four aspects of the lanthionine synthetase were investigated.
Aided by a hybrid ligation protocol that allowed us to install syntheticcore peptides onto a heterologously expressed leader peptide, we investigated
the directionality of both dehydration andcyclization, the possibility
that a non-enzymaticcyclization step might account for the high diversity
of ring topologies of the products, and the possibility of reversibility
of ring formation. Use of labeled ProcA substrate unequivocally demonstrated
that ProcM dehydrates two very different substrate peptides in a C-to-N-terminal
fashion. This same directionality was also reported for the class
III lanthipeptide synthetase LabKC[43] and another RiPP synthetase BalhCD,[44] whereas for other class II lanthipeptides, such as LctM and HalM2,
the directionality of dehydration was reported to be N-to-C-terminal
based on tandem MS.[30] The latter directionality
is more readily explained using a proximity effect if the active site
for dehydration is close to the leader peptide binding site. Such
a model might be expected to lead to an erosion of strict directionality
if Ser/Thr residues are close in sequence space, which indeed has
been observed.[30] Explanation of a C-to-N-terminal
directionality of dehydration as observed here and in LabKC and BalhCD
requires a more complex model. Although we cannot completely rule
out that the directionality of dehydration by ProcM is simply reflecting
the reactivity of each individual site as a result of different flanking
residues or secondary structure, the lack of any sequence similarity
in the two peptides that are both shown to be dehydrated in C-to-N-terminal
direction in this study leads us to favor an explanation that involves
a specific juxtaposition of the leader andcore peptide binding sites
that favors dehydration of C-terminal residues. Structural studies
will be required to provide further information.Interestingly,
the cyclization of the two peptides also occurred
with a specific order, but this order was not necessarily directional.
Whereas for ProcA2.8 the Cys that is locatedcloser to the C-terminus
reacted first, in ProcA3.3, it was the Cys that was closer to the
N-terminus that appeared to react first. In the latter substrate,
this results in the smaller B-ring being formed in the observed intermediate.
Preference for formation of a smaller ring was also observed when
Cys14 of ProcA3.3 was protected, resulting in Cys21 forming a ring
that is not seen in the normal product. Hence, it appears that the
order of cyclization catalyzed by ProcM is determined more by the
ring size than by directionality of the enzyme. This observation agrees
with other recent studies that suggest that the precursor peptides
may have an inherent bias for formation of certain rings.[45,46]The remarkable substrate tolerance of ProcM suggested the
possibility
that perhaps only a subset of the rings are generated enzymatically
and that these enzymatically formed macrocycles preorganize the peptide
for subsequent non-enzymaticcyclization. However, our current data
show that, for two different substrates, non-enzymaticcyclization
of intermediates that contain one ring is too slow to be kinetically
competent for the enzymatic process. Another question that has not
been previously addressed in lanthipeptide biosynthesis is whether
thioether ring formation is reversible or not. Our experiments suggest
that enzymaticdeprotonation at the α-position of MeLan residues
does occur in some rings. Furthermore, although true kinetic studies
on the enzyme have thus far been unsuccessful because of the many
reactions it catalyzes and the absence of a convenient and quantitative
method to measure each step, the general time dependence of exchange
andcyclization of ProcA3.3 suggests that deprotonation at the α-carbon
of MeLan might be kinetically competent. It is important to note that
the D–H exchange assay reports on the reversibility
of the protonation of the enolateduring MeLan formation;
it does not necessarily indicate that the cyclization is reversible
(i.e., a reversible Michael-type reaction). Attempts to trap a free
thiol formed from ring opening involving Lan/MeLan residues were not
successful.The observation that the deuterium in the smaller
B-ring exchanges
faster than the larger A-ring is somewhat puzzling. If deuterium exchange
indeed reports on reversibility of ring formation, then one might
have expected that the ring that forms last (A-ring) would open up
first. Several explanations may account for the observation that D–H
exchange instead occurs in the B-ring. One possibility is that the
formation of the two rings are entirely independent, that is, that
the kinetics of forming either ring is independent of whether the
other ring is already formed (Figure S24). In this scenario, an intermediate
with the smaller B-ring installed would indeed be observed in the
forward process, and exchange of the same ring could be favored in
the reverse process (Figure S24). Although it appears unlikely that
ring formation would be entirely independent in a short peptide with
overlapping rings such as the ProcA3.3 core peptide, we cannot rule
out this possibility. A second possibility is that the intermediate
with the B-ring that is observedduring the ring formation process
is not a productive intermediate en route to the final product. It
is possible that formation of the final product requires the A-ring
to be formed first (Figure S25). In that scenario, the intermediate
with the B-ring formed would be in equilibrium with the starting peptide,
and an intermediate with the A-ring installed would not be detected
because of very rapid formation of the final product from this intermediate
(Figure S25). This model would also readily explain why it is the
B-ring that undergoes exchange in the reverse direction. We cannot
unambiguously distinguish between both hypotheses, but they do make
predictions that can be tested in future studies.
Conclusions
This study shows that dehydration of ProcA2.8 and ProcA3.3 by ProcM
takes place with C-to-N directionality, and that for these two substrates,
cyclization is also an ordered process but that the order is determined
by the ring topology. Furthermore, non-enzymaticcyclization is shown
not to be involved in the formation of two very different ring topologies
in prochlorosins 2.8 and 3.3. Whether these observations are general
for all ProcA substrates remains to be determined. Finally, for some
ring topologies, the protonation of the enolateduring the Michael-type
addition is reversible (i.e., the enzyme can remove the α-proton
from the cyclized product), which possibly may indicate that the enzyme
can also catalyze a retro-Michael addition. Future studies will focus
on investigating this hypothesis.
Authors: Kathrin Meindl; Timo Schmiederer; Kathrin Schneider; Andreas Reicke; Diane Butz; Simone Keller; Hans Gühring; László Vértesy; Joachim Wink; Holger Hoffmann; Mark Brönstrup; George M Sheldrick; Roderich D Süssmuth Journal: Angew Chem Int Ed Engl Date: 2010-02-01 Impact factor: 15.336
Authors: M Violet Lee; Leigh Anne Furgerson Ihnken; Young Ok You; Amanda L McClerren; Wilfred A van der Donk; Neil L Kelleher Journal: J Am Chem Soc Date: 2009-09-02 Impact factor: 15.419
Authors: Julian D Hegemann; Silvia C Bobeica; Mark C Walker; Ian R Bothwell; Wilfred A van der Donk Journal: ACS Synth Biol Date: 2019-05-08 Impact factor: 5.110
Authors: Manuel A Ortega; Yue Hao; Mark C Walker; Stefano Donadio; Margherita Sosio; Satish K Nair; Wilfred A van der Donk Journal: Cell Chem Biol Date: 2016-02-11 Impact factor: 8.116